Zacks Investment Research Upgrades Lantheus Holdings Inc. (LNTH) to Buy
Lantheus Holdings Inc. (NASDAQ:LNTH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The firm presently has a $9.50 price target on the stock. Zacks Investment Research’s price objective indicates a potential upside of 12.43% from the company’s current price.
According to Zacks, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. “
LNTH has been the topic of several other reports. Credit Suisse Group AG assumed coverage on Lantheus Holdings in a research note on Friday, September 23rd. They set a “neutral” rating and a $8.00 price objective on the stock. Jefferies Group reiterated a “buy” rating on shares of Lantheus Holdings in a research note on Friday, August 5th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $7.90.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/18/zacks-investment-research-upgrades-lantheus-holdings-inc-lnth-to-buy.html
Shares of Lantheus Holdings (NASDAQ:LNTH) opened at 8.45 on Tuesday. The company has a 50-day moving average of $8.49 and a 200-day moving average of $4.75. The firm has a market capitalization of $256.77 million, a PE ratio of 9.54 and a beta of 0.47. Lantheus Holdings has a 52 week low of $1.76 and a 52 week high of $10.10.
Lantheus Holdings (NASDAQ:LNTH) last announced its quarterly earnings data on Thursday, August 4th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.18. Lantheus Holdings had a negative return on equity of 11.75% and a net margin of 9.00%. The firm had revenue of $78 million for the quarter, compared to analysts’ expectations of $72.66 million. On average, equities analysts forecast that Lantheus Holdings will post $0.55 earnings per share for the current fiscal year.
A number of large investors have recently bought and sold shares of the stock. Paloma Partners Management Co bought a new stake in shares of Lantheus Holdings during the second quarter worth $179,000. Brigade Capital Management LP bought a new stake in shares of Lantheus Holdings during the second quarter worth $5,219,000. Spark Investment Management LLC boosted its stake in shares of Lantheus Holdings by 33.2% in the second quarter. Spark Investment Management LLC now owns 141,300 shares of the company’s stock worth $518,000 after buying an additional 35,200 shares in the last quarter. TFS Capital LLC bought a new stake in shares of Lantheus Holdings during the second quarter worth $156,000. Finally, Globeflex Capital L P bought a new stake in shares of Lantheus Holdings during the second quarter worth $1,410,000. Institutional investors own 30.15% of the company’s stock.
About Lantheus Holdings
Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.